Canada markets close in 5 hours 23 minutes

Cutera, Inc. (CUTR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.4650-0.0750 (-4.87%)
As of 10:35AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close1.5400
Open1.5300
Bid1.4400 x 200
Ask1.5000 x 200
Day's Range1.3850 - 1.5400
52 Week Range1.2800 - 21.4100
Volume555,345
Avg. Volume765,469
Market Cap29.443M
Beta (5Y Monthly)1.42
PE Ratio (TTM)N/A
EPS (TTM)-7.9100
Earnings DateAug 06, 2024 - Aug 12, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.33
  • Business Wire

    Cutera® Announces New Survey Data During Acne Awareness Month

    BRISBANE, Calif., June 13, 2024--Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announces the release of important new acne survey data as part of June’s Acne Awareness Month. The findings highlight the impact of acne on individuals and emphasize the substantial role of novel treatments like AviClear®, the first FDA-cleared energy-based device for the long-term treatment of mild, moderate, and severe inflammatory acne, in improving quality of life.

  • Business Wire

    Cutera® Appoints Jeryl L. Hilleman to Board of Directors

    BRISBANE, Calif., June 10, 2024--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that Jeryl "Jeri" Hilleman will join its Board of Directors, effective July 12, 2024.

  • Business Wire

    Cutera® Announces AviClear® Investor Webinar

    BRISBANE, Calif., June 07, 2024--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will hold an investor webinar at 11 a.m. PDT on June 20, 2024, to present an overview of AviClear, the first FDA-cleared energy device for the long-term treatment of mild, moderate, and severe inflammatory acne. The webinar will include a review of clinical data, market opportunity, future clinical studies, and real-world user experience.